title: The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
authors.affiliation: Health Strategies International, Orinda, California 94563, USA. emarseille@home.com
authors.forename: E
authors.initials: E
authors.lastname: Marseille
authors.forename: J G
authors.initials: JG
authors.lastname: Kahn
authors.forename: F
authors.initials: F
authors.lastname: Mmiro
authors.forename: L
authors.initials: L
authors.lastname: Guay
authors.forename: P
authors.initials: P
authors.lastname: Musoke
authors.forename: M G
authors.initials: MG
authors.lastname: Fowler
authors.forename: J B
authors.initials: JB
authors.lastname: Jackson
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000517:prevention & control* / Q000635:transmission*; D017954:Africa South of the Sahara; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D005260:Female; D015528:HIV Seroprevalence; D015497:HIV-1; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D015233:Models, Statistical; D009035:Mothers; D019829:Nevirapine / Q000191:economics / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D014454:Uganda
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine